Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMRT vs IMRT + Cisplatin in Stage II Nasopharyngeal Carcinoma
NCT03068936Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Mar 2017
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03068936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03068936.